Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Lancet HIV. 2020 Dec 18;8(4):e216–e224. doi: 10.1016/S2352-3018(20)30279-4

Figure 1: Influence of varying healthcare costs on ICERS by clinic volume.

Figure 1:

ART, antiretroviral therapy; DALY, disability-adjusted life years; ICER, incremental cost-effectiveness ratio. Clinic volume is defined as number of ART initiations per month. The solid red line represents the cost-effectiveness threshold of $500 and per DALY averted and the dashed red line represents the threshold of $1,175 per DALY averted.